AU2007229457A1 - Inhibitors of protein prenyltransferases - Google Patents

Inhibitors of protein prenyltransferases Download PDF

Info

Publication number
AU2007229457A1
AU2007229457A1 AU2007229457A AU2007229457A AU2007229457A1 AU 2007229457 A1 AU2007229457 A1 AU 2007229457A1 AU 2007229457 A AU2007229457 A AU 2007229457A AU 2007229457 A AU2007229457 A AU 2007229457A AU 2007229457 A1 AU2007229457 A1 AU 2007229457A1
Authority
AU
Australia
Prior art keywords
compound
compounds
ggtase
salt
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007229457A
Other languages
English (en)
Inventor
Hannah Fiji
Ohyun Kwon
Fuyuhiko Tamanoi
Masaru Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2007229457A1 publication Critical patent/AU2007229457A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2007229457A 2006-03-22 2007-03-22 Inhibitors of protein prenyltransferases Abandoned AU2007229457A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78444306P 2006-03-22 2006-03-22
US60/784,443 2006-03-22
PCT/US2007/007135 WO2007111948A2 (en) 2006-03-22 2007-03-22 Inhibitors of protein prenyltransferases

Publications (1)

Publication Number Publication Date
AU2007229457A1 true AU2007229457A1 (en) 2007-10-04

Family

ID=38541651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007229457A Abandoned AU2007229457A1 (en) 2006-03-22 2007-03-22 Inhibitors of protein prenyltransferases

Country Status (7)

Country Link
US (1) US8093274B2 (US20040106767A1-20040603-C00005.png)
EP (1) EP2007383A4 (US20040106767A1-20040603-C00005.png)
JP (1) JP2009530392A (US20040106767A1-20040603-C00005.png)
CN (1) CN101431996A (US20040106767A1-20040603-C00005.png)
AU (1) AU2007229457A1 (US20040106767A1-20040603-C00005.png)
CA (1) CA2647038A1 (US20040106767A1-20040603-C00005.png)
WO (1) WO2007111948A2 (US20040106767A1-20040603-C00005.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
SG171690A1 (en) 2005-03-22 2011-06-29 Harvard College Treatment of protein degradation disorders
WO2008091349A1 (en) 2006-02-14 2008-07-31 The President And Fellows Of Harvard College Bifunctional histone deacetylase inhibitors
AU2007229457A1 (en) 2006-03-22 2007-10-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases
AU2007248656B2 (en) * 2006-05-03 2013-04-04 Dana-Farber Cancer Institute, Inc. Histone deacetylase and tubulin deacetylase inhibitors
KR101708946B1 (ko) 2008-07-23 2017-02-21 다나-파버 캔서 인스티튜트 인크. 탈아세틸화제 억제제 및 그것의 용도
WO2010014054A1 (en) * 2008-07-28 2010-02-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases
US9125821B2 (en) 2008-07-28 2015-09-08 The Regents Of The University Of California Nanodrug targeting protein geranylgeranylation
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
WO2012097371A2 (en) * 2011-01-14 2012-07-19 The Regents Of The University Of California Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
US10197557B2 (en) * 2011-02-24 2019-02-05 The Regents Of The University Of California Small molecules for endothelial cell activation
SG194875A1 (en) 2011-05-08 2013-12-30 Legochem Biosciences Inc Protein-active agent conjugates and method for preparing the same
EP2836482B1 (en) * 2012-04-10 2019-12-25 The Regents of The University of California Compositions and methods for treating cancer
WO2019076269A1 (zh) 2017-10-16 2019-04-25 清华大学 甲羟戊酸通路抑制剂及其药物组合物
CN112574041B (zh) * 2020-12-25 2022-10-28 温州大学新材料与产业技术研究院 一种手性β羟基1,3-二羰基类化合物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
WO2004015130A2 (en) 2002-08-07 2004-02-19 Exelixis Modulators of rabggt and methods of use thereof
BRPI0410630A (pt) * 2003-06-19 2006-06-13 Pfizer Prod Inc antagonista de nk1
AU2007229457A1 (en) 2006-03-22 2007-10-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases

Also Published As

Publication number Publication date
EP2007383A2 (en) 2008-12-31
CA2647038A1 (en) 2007-10-04
CN101431996A (zh) 2009-05-13
JP2009530392A (ja) 2009-08-27
EP2007383A4 (en) 2010-09-15
WO2007111948A3 (en) 2008-08-07
US8093274B2 (en) 2012-01-10
WO2007111948A2 (en) 2007-10-04
US20100063114A1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
US8093274B2 (en) Inhibitors of protein prenyltransferases
US8815935B2 (en) Inhibitors of protein prenyltransferases
Bai et al. Peptidomimetic α-acyloxymethylketone warheads with six-membered lactam P1 glutamine mimic: SARS-CoV-2 3CL protease inhibition, coronavirus antiviral activity, and in vitro biological stability
AU690656B2 (en) Sulfonamide derivatives and their use
AU2012345863B2 (en) Aryl dihydropyridinones and piperidinones as MGAT2 inhibitors
CN105358532B (zh) 杂环化合物和它们的使用方法
WO2011044073A1 (en) Pyrrolidine gpr40 modulators
CA2861066A1 (en) Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an e3 ubiquitin ligase
CN107849011A (zh) 作为bace1抑制剂的2‑氨基‑3‑氟‑3‑(氟甲基)‑6‑甲基‑6‑苯基‑3,4,5,6‑四氢吡啶
NO316117B1 (no) Inhibitorer for farnesyl-protein-transferase, anvendelse av dem og farmasöytiske preparater inneholdende dem
MX2008015638A (es) Acidos fenil aceticos sustituidos como antagonistas de dp-2.
Zhu et al. Structure-based discovery of selective BRPF1 bromodomain inhibitors
US20030187027A1 (en) Dioxanes and uses thereof
Mariaule et al. 3-Oxo-hexahydro-1 H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors
Chamakuri et al. Synthesis of enantiomerically pure 6-substituted-piperazine-2-acetic acid esters as intermediates for library production
Staas et al. Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability
Balog et al. The synthesis and evaluation of [2.2. 1]-bicycloazahydantoins as androgen receptor antagonists
EP2334658A2 (en) Ortho-aminoanilides for the treatment of cancer
EP2280940A1 (en) Novel n-(2-amino-phenyl)-acrylamides
Saha et al. Novel triazole based inhibitors of Ras farnesyl transferase
Mai et al. New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme-and cell-based investigations
Hanessian et al. Design and synthesis of MMP inhibitors using N-arylsulfonylaziridine hydroxamic acids as constrained scaffolds
Astles et al. Diamine containing VLA-4 antagonists
WO2005057171A2 (en) Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
Liu Novel concepts and methodologies in pseudo natural product chemistry

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period